Harvard Bioscience (HBIO) Price & Analysis

Compare

274 Followers

HBIO Stock Chart & Stats

$0.40

-$0.02(-0.93%)

At close: Jan 08 4:00 PM EST

$0.40

-$0.02(-0.93%)

Day’s Range― - ―

52-Week Range$0.28 - $2.28

Previous CloseN/A

Volume27.75K

Average Volume (3M)1.04M

Market Cap

$33.63M

Enterprise Value$55.51M

Total Cash (Recent Filing)$6.82M

Total Debt (Recent Filing)$42.78M

Price to Earnings (P/E)―

Beta2.12

Next Earnings

Mar 05, 2026

EPS Estimate

0.04

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding44,579,666

10 Day Avg. Volume748,703

30 Day Avg. Volume1,038,303

Financial Highlights & Ratios

PEG Ratio-0.03

Price to Book (P/B)1.45

Price to Sales (P/S)0.98

P/FCF Ratio-76.30

Enterprise Value/Market Cap1.65

Enterprise Value/Revenue0.64

Enterprise Value/Gross Profit1.14

Enterprise Value/Ebitda-1.27

Forecast

1Y Price Target

$2.00

Price Target Upside400.00% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)0.03

Revenue Forecast (FY)$85.30M

Bulls Say, Bears Say

Bulls Say

Financial PerformanceHarvard Bioscience's 3Q revenue beat consensus and gross margins improved year-over-year, driven by strong sales execution and financial discipline.

Operational ImprovementsAdjusted EBITDA improved year-over-year to $2.0 million, surpassing estimates due to expense discipline, benefits from a new ERP system, and a more profitable sales mix from consumables.

Product DemandAn expanding backlog and demand for new products prompted a 4Q guide ahead of consensus.

Bears Say

Government FundingA continuation of the government shutdown and a delay in the release of NIH funding would imply revenue at the lower end of the guidance range.

Harvard Bioscience News

Harvard Bioscience enters agreement with BroadOak Capital Partners

Harvard Bioscience (HBIO) entered into an agreement with BroadOak Capital Partners to provide a $40M credit facility comprised...

7d ago

HBIO

Harvard Bioscience Secures $40M Loan Agreement

Harvard Bioscience ( ($HBIO) ) has provided an update. On December 17, 2025, Harvard Bioscience finalized a $40...

7d ago

HBIO

Harvard Bioscience Engages in Credit Agreement Discussions

Harvard Bioscience ( ($HBIO) ) has issued an announcement. Harvard Bioscience is engaged in ongoing discussions to address...

19d ago

HBIO

Harvard Bioscience’s Earnings Call: Optimism Amid Challenges

Harvard Bioscience (($HBIO)) has held its Q3 earnings call. Read on for the main highlights of the call....

2M ago

HBIO

Harvard Bioscience Reports Q3 2025 Financial Results

Harvard Bioscience ( ($HBIO) ) has released its Q3 earnings. Here is a breakdown of the information Harvard...

2M ago

HBIO

Harvard Bioscience sees Q4 revenue $22.5M-$24.5M

The Company expects fourth quarter 2025 revenues of $22.5 million to $24.5 million and gross margin in the...

2M ago

HBIO

Harvard Bioscience reports Q3 adjusted EPS 0c vs. (2c) last year

Reports Q3 revenue $20.6M vs. $22M last year. “Our third-quarter performance highlights our growth opportunity while we advance...

2M ago

HBIO

HBIO Upcoming Earnings Report: What to Expect?

Harvard Bioscience (HBIO) is scheduled to report 3rd quarter earnings on 11/06/2025, before the market opens. Regarding Q3...

2M ago

HBIO

Harvard Bioscience Granted Nasdaq Compliance Extension

Harvard Bioscience ( ($HBIO) ) just unveiled an announcement. On October 2, 2025, Harvard Bioscience received a notification...

3M ago

HBIO

Harvard Bioscience expands distribution agreement with Fisher Scientific

Harvard Bioscience (HBIO) announce the expansion of its distribution agreement with Fisher Scientific, a part of Thermo Fisher...

3M ago

TMO

HBIO

Harvard Bioscience price target lowered to $2 from $3 at Benchmark

Benchmark analyst Bruce Jackson lowered the firm’s price target on Harvard Bioscience (HBIO) to $2 from $3 and...

4M ago

HBIO

Resilient Performance and Strategic Growth Drive Buy Rating for Harvard Bioscience Amid Market Challenges

Benchmark Co. analyst Bruce Jackson maintained a Buy rating on Harvard Bioscience today and set a price target...

4M ago

HBIO

Harvard Bioscience Appoints Stephen DeNelsky to Board

Harvard Bioscience ( ($HBIO) ) just unveiled an update. On September 5, 2025, Harvard Bioscience appointed Stephen DeNelsky...

4M ago

HBIO

Harvard Bioscience appoints DeNelsky to board of directors

Harvard Bioscience (HBIO) announced the appointment of Stephen DeNelsky to its Board of Directors, effective September 5, 2025....

4M ago

HBIO

HBIO FAQ

What was Harvard Bioscience’s price range in the past 12 months?

Harvard Bioscience lowest stock price was $0.28 and its highest was $2.28 in the past 12 months.

What is Harvard Bioscience’s market cap?

Harvard Bioscience’s market cap is $33.63M.

When is Harvard Bioscience’s upcoming earnings report date?

Harvard Bioscience’s upcoming earnings report date is Mar 05, 2026 which is in 71 days.

How were Harvard Bioscience’s earnings last quarter?

Harvard Bioscience released its earnings results on Nov 06, 2025. The company reported $0 earnings per share for the quarter, missing the consensus estimate of $0.005 by -$0.005.

Is Harvard Bioscience overvalued?

According to Wall Street analysts Harvard Bioscience’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Harvard Bioscience pay dividends?

Harvard Bioscience does not currently pay dividends.

What is Harvard Bioscience’s EPS estimate?

Harvard Bioscience’s EPS estimate is 0.04.

How many shares outstanding does Harvard Bioscience have?

Harvard Bioscience has 44,579,666 shares outstanding.

What happened to Harvard Bioscience’s price movement after its last earnings report?

Harvard Bioscience reported an EPS of $0 in its last earnings report, missing expectations of $0.005. Following the earnings report the stock price went down -8.475%.

Which hedge fund is a major shareholder of Harvard Bioscience?

Currently, no hedge funds are holding shares in HBIO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Harvard Bioscience Stock Smart Score

Neutral

Fundamentals

Return on Equity

-135.62%

Trailing 12-Months

Asset Growth

-40.57%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Harvard Bioscience

Harvard Bioscience (HBIO) is a global developer and manufacturer of a broad range of tools and instruments for life science research and drug development. The company operates in the biotechnology sector, focusing on providing innovative solutions for researchers in academic, pharmaceutical, and biotechnology environments. Its core products include advanced laboratory instruments, such as microinjection systems, electrophysiology equipment, and various assays and consumables that facilitate biological research and development.

Harvard Bioscience (HBIO) Earnings & Revenues

Historic Earnings Reports

HBIO Company Deck

HBIO Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call highlighted strong operational improvements, a significant increase in backlog and order growth, successful product launches, and positive cash flow management. However, these positives were somewhat offset by year-over-year revenue decline, challenges in the China market, and uncertainty due to the U.S. government shutdown affecting NIH funding. Overall, the company's efforts to enhance operational efficiency and increase product demand reflect a positive outlook despite some ongoing challenges.View all HBIO earnings summaries

HBIO Stock 12 Month Forecast

Average Price Target

$2.00

▲(400.00% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","2":"$2","3":"$3","-1":"-$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$2.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0,1,2,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.76,0.8553846153846154,0.9507692307692308,1.0461538461538462,1.1415384615384616,1.236923076923077,1.3323076923076922,1.4276923076923076,1.523076923076923,1.6184615384615384,1.7138461538461538,1.8092307692307692,1.9046153846153846,{"y":2,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.76,0.8553846153846154,0.9507692307692308,1.0461538461538462,1.1415384615384616,1.236923076923077,1.3323076923076922,1.4276923076923076,1.523076923076923,1.6184615384615384,1.7138461538461538,1.8092307692307692,1.9046153846153846,{"y":2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.76,0.8553846153846154,0.9507692307692308,1.0461538461538462,1.1415384615384616,1.236923076923077,1.3323076923076922,1.4276923076923076,1.523076923076923,1.6184615384615384,1.7138461538461538,1.8092307692307692,1.9046153846153846,{"y":2,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.4,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.2,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.11,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.84,"date":1740787200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.59,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.34,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.4,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.45,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.44,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.49,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.45,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.52,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.76,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >